Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.

Eitemau Tebyg

• Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.
  gan: Olotu, A, et al.
  Cyhoeddwyd: (2011)
• Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial
  gan: Olotu, A, et al.
  Cyhoeddwyd: (2011)
• PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDREN
  gan: Bejon, P, et al.
  Cyhoeddwyd: (2008)
• Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
  gan: Lusingu, J, et al.
  Cyhoeddwyd: (2010)
• Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
  gan: Bejon, P, et al.
  Cyhoeddwyd: (2011)